🌎 Super Micro Computer Initiated, Ingredion Upgraded, Cleveland-Cliffs Downgraded and more…

🌎 Super Micro Computer Initiated, Ingredion Upgraded, Cleveland-Cliffs Downgraded…

February 15, 2024
by RJ Hamster

VIEW MY PORTFOLIO

February 15th, 2024

When AAPL crosses the profit line… look out (ad)

Imagine focusing on only the best stock in the world…

And only trading it just a handful of times per year…

And absolutely crushing the performance of pretty much every top hedge fund out there.

That’s the idea behind this new trade setup.

Tap Here to See How it Works

Today’s Top Stories

S&P 500’s surge to new highs: Bull trap hiding in plain sight?

Eni and TotalEnergies are swiftly developing natural gas deposits off Cyprus to supply Europe

This Stock Could Go Up 66% or More. (Chaikin Analytics)

Impinj stock surges on strong earnings and guidance

Musk pushes forward on transfer of legal home for SpaceX from Delaware, to Texas

Pfizer at 10-year support: Is it a massive buy opportunity?

Cleveland-Cliffs to shutter West Virginia tin plant and lay off 900 after tariff ruling

Wall Street Legend: “Buy this A.I. stock NOW” (Chaikin Analytics)

Restaurant Brands expands its Burger King franchise empire

Ford CEO says company will rethink where it builds vehicles after last year’s autoworkers strike

Gene therapy: Why does it cost millions for a single treatment?

Greek farmers decide to take their protests to Athens and expand roadblock campaign

Quick Links

MarketBeat All Access

Unlock the Power of Tomorrow with the #1 Alternative Energy Stock! (ad)

Are you ready to invest in a brighter, greener future? Look no further – the #1 Alternative Energy Stock is here, leading the charge towards sustainable and profitable solutions!
By clicking link you are subscribing to The Darwin Investor Network and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here.

Download your complimentary copy now!

Your Watchlist (Manage Your Watchlist and Monitor Your Portfolio)

Apple Inc. (AAPL)
- Apple Inc. (NASDAQ:AAPL) announced a quarterly dividend on Thursday, February 1st. Stockholders of record on Monday, February 12th will be paid a dividend of 0.24 per share by the iPhone maker on Thursday, February 15th. This represents a $0.96 dividend on an annualized basis and a dividend yield of 0.53%. The ex-dividend date of this dividend is Friday, February 9th.
- (2/15) S&P 500’s surge to new highs: Bull trap hiding in plain sight? (AAPL)(marketbeat.com)
- (2/15) Buffett Dumps Apple Shares (247wallst.com)
- (2/15) It’s Time for Apple to Raise Its Paltry Dividend (msn.com)
- (2/15) AAPL Stock Outlook: Pick Up the Phone! $200 Is Calling. (msn.com)
- (2/15) Apple Q1 Earnings Transcript (marketbeat.com)
- (2/15) Tilson Financial Group Inc. Invests $1.23 Million in Apple Inc. (NASDAQ:AAPL) (marketbeat.com)
- (2/15) Apple Inc. (AAPL) (au.finance.yahoo.com)
- (2/15) Mairs and Power Amplifies Stake in Apple Inc by 288.63%(finance.yahoo.com)
- (2/15) Apple Inc. (NASDAQ:AAPL) Receives Consensus Rating of “Moderate Buy” from Analysts (marketbeat.com)
- (2/14) Mark Zuckerberg Claims Oculus Outshines Apple Vision Pro: But Is It Better For Crypto Adoption? (bitcoinist.com)
Amazon.com, Inc. (AMZN)
- CEO Douglas J. Herrington sold 14,300 shares of the firm’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $175.00, for a total value of $2,502,500.00. Following the sale, the chief executive officer now directly owns 499,831 shares in the company, valued at $87,470,425. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.
- (2/15) Analysts’ Opinions Are Mixed on These Consumer Cyclical Stocks: Amazon (AMZN) and e.l.f. Beauty (ELF) (markets.businessinsider.com)
- (2/15) AI Frenzy Propels Nvidia Above Google And Amazon As 4th Most Valuable Company — Also Makes Rival AMD’s CEO A Billionaire (msn.com)
- (2/15) S&P 500’s surge to new highs: Bull trap hiding in plain sight? (AMZN)(marketbeat.com)
- (2/15) ‘Big Short’ investor Michael Burry reveals bets on Amazon and Alphabet(markets.businessinsider.com)
- (2/15) Amazon.com Q4 Earnings Transcript (marketbeat.com)
- (2/15) Amazon.com, Inc. (NASDAQ:AMZN) Stake Lowered by Vestmark Advisory Solutions Inc. (marketbeat.com)
- (2/15) Short Interest in Amazon.com, Inc. (NASDAQ:AMZN) Declines By 11.4%(marketbeat.com)
- (2/14) Italian Regulator Slaps €7M Fine on Amazon (NASDAQ:AMZN) and BAT for Deceptive Tobacco Ads (msn.com)
- (2/14) Bezos Sells $2 Bln Worth Of Shares In Second Amazon Sale(markets.businessinsider.com)
- (2/14) Hedge Funds Add Amazon and Intel While Cutting Nike and Pfizer, Filings Show (finance.yahoo.com)
Alphabet Inc. (GOOGL)
Meta Platforms, Inc. (META)
- CEO Mark Zuckerberg sold 34,398 shares of the company’s stock in a transaction on Wednesday, February 14th. The stock was sold at an average price of $469.69, for a total value of $16,156,396.62. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.
- CEO Mark Zuckerberg sold 34,398 shares of the business’s stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $473.32, for a total value of $16,281,261.36. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.
- (2/15) Meta Steers Users Away From New Apple Fees in Latest Spat Between Tech Giants (msn.com)
- (2/15) Meta Adds Broadcom CEO to Board, TSMC Stock Hits Record High, and Other Tech News Today (finance.yahoo.com)
- (2/15) TikTok, Facebook and YouTube sued by New York City for alleged harm to kids’ mental health (cnbc.com)
- (2/14) New York Mayor sues social media firms for fueling youth mental health crisis (finance.yahoo.com)
- (2/14) UPDATE 2-New York Mayor sues social media firms for fueling youth mental health crisis (finance.yahoo.com)
- (2/14) Meta Paid About $500 Million to Broadcom for Components in 2023(money.usnews.com)
- (2/14) Meta Adds Two New Board Directors With Sandberg Set to Depart(finance.yahoo.com)
- (2/14) Tinder, Hinge and other dating apps encourage ‘compulsive’ use, lawsuit claims (marketbeat.com)
- (2/14) Meta Platforms, Inc. (NASDAQ:META) is Atika Capital Management LLC’s 8th Largest Position (marketbeat.com)
- (2/14) Russia’s Covert Troll Farms Are Failing: Meta Report (news.yahoo.com)
Microsoft Co. (MSFT)

Analysts’ Upgrades

Air Products and Chemicals (NYSE:APD) was upgraded by analysts at Bank of America Co. from a “neutral” rating to a “buy” rating. They now have a $264.00 price target on the stock. This represents a 16.2% upside from the current price of $227.10.
Coinbase Global (NASDAQ:COIN) was upgraded by analysts at JPMorgan Chase & Co. from an “underweight” rating to a “neutral” rating. They now have a $80.00 price target on the stock. This represents a 52.3% downside from the current price of $167.60.
Entegris (NASDAQ:ENTG) was upgraded by analysts at Craig Hallum from a “hold” rating to a “buy” rating. They now have a $150.00 price target on the stock. This represents a 11.6% upside from the current price of $134.40.
Eversource Energy (NYSE:ES) was upgraded by analysts at Mizuho from a “neutral” rating to a “buy” rating. They now have a $62.00 price target on the stock, up previously from $54.00. This represents a 7.2% upside from the current price of $57.81.
Inogen (NASDAQ:INGN) was upgraded by analysts at William Blair from a “market perform” rating to an “outperform” rating.The current price is $9.98.
Ingredion (NYSE:INGR) was upgraded by analysts at The Goldman Sachs Group, Inc. from a “neutral” rating to a “buy” rating. They now have a $135.00 price target on the stock, up previously from $122.00. This represents a 19.2% upside from the current price of $113.26.
Medpace (NASDAQ:MEDP) was upgraded by analysts at UBS Group AG from a “neutral” rating to a “buy” rating. They now have a $452.00 price target on the stock, up previously from $282.00. This represents a 15.8% upside from the current price of $390.34.
Manulife Financial (NYSE:MFC) (TSE:MFC) was upgraded by analysts at BMO Capital Markets from a “market perform” rating to an “outperform” rating. They now have a $35.00 price target on the stock, up previously from $31.00. This represents a 44.3% upside from the current price of $24.25.
Molina Healthcare (NYSE:MOH) was upgraded by analysts at Wells Fargo & Company from an “underweight” rating to an “equal weight” rating. They now have a $420.00 price target on the stock, up previously from $367.00. This represents a 5.7% upside from the current price of $397.44.
Outlook Therapeutics (NASDAQ:OTLK) was upgraded by analysts at Chardan Capital from a “neutral” rating to a “buy” rating. They now have a $3.00 price target on the stock. This represents a 538.3% upside from the current price of $0.47.
Similarweb (NYSE:SMWB) was upgraded by analysts at Citigroup Inc. from a “neutral” rating to a “buy” rating. They now have a $10.00 price target on the stock, up previously from $6.00. This represents a 27.4% upside from the current price of $7.85.
Teradyne (NASDAQ:TER) was upgraded by analysts at JPMorgan Chase & Co. from an “underweight” rating to a “neutral” rating. They now have a $100.00 price target on the stock, up previously from $90.00. This represents a 2.2% downside from the current price of $102.20.
View today’s most recent analysts’ upgrades at MarketBeat.com

Is this AI’s biggest breakthrough to date? (ad)

image for Is this AI's biggest breakthrough to date?

In the past year, AI has amazed us all with its achievements. It can predict weather, recommend winning stocks, create original art, write computer code, detect skin cancer – and, shockingly, it can do all these things better than most humans. But when you see its latest leap (revealed in on-location footage), you may want to pinch yourself!

Get the full scoop here

Analysts’ Downgrades

Akamai Technologies (NASDAQ:AKAM) was downgraded by analysts at HSBC Holdings plc from a “hold” rating to a “reduce” rating. They now have a $96.00 price target on the stock, down previously from $109.00. This represents a 15.0% downside from the current price of $112.96.
Cleveland-Cliffs (NYSE:CLF) was downgraded by analysts at Morgan Stanley from an “overweight” rating to an “equal weight” rating. They now have a $20.00 price target on the stock, down previously from $21.50. This represents a 1.2% upside from the current price of $19.77.
Comcast (NASDAQ:CMCSA) was downgraded by analysts at Redburn Atlantic from a “buy” rating to a “neutral” rating. They now have a $44.00 price target on the stock, down previously from $50.00. This represents a 4.9% upside from the current price of $41.93.
Charles River Laboratories International (NYSE:CRL) was downgraded by analysts at Guggenheim from a “buy” rating to a “neutral” rating.The current price is $239.80.
Fastly (NYSE:FSLY) was downgraded by analysts at Craig Hallum from a “buy” rating to a “hold” rating. They now have a $20.00 price target on the stock. This represents a 19.1% upside from the current price of $16.79.
Generac (NYSE:GNRC) was downgraded by analysts at Guggenheim from a “buy” rating to a “neutral” rating.The current price is $117.84.
IPG Photonics (NASDAQ:IPGP) was downgraded by analysts at Citigroup Inc. from a “neutral” rating to a “sell” rating. They now have a $74.00 price target on the stock, down previously from $111.00. This represents a 17.1% downside from the current price of $89.25.
IQVIA (NYSE:IQV) was downgraded by analysts at Guggenheim from a “buy” rating to a “neutral” rating.The current price is $239.90.
Keysight Technologies (NYSE:KEYS) was downgraded by analysts at JPMorgan Chase & Co. from an “overweight” rating to a “neutral” rating. They now have a $170.00 price target on the stock, down previously from $184.00. This represents a 9.8% upside from the current price of $154.82.
Owens Corning (NYSE:OC) was downgraded by analysts at Evercore ISI from an “outperform” rating to an “in-line” rating. They now have a $154.00 price target on the stock, down previously from $163.00. This represents a 8.6% upside from the current price of $141.80.
Snowflake (NYSE:SNOW) was downgraded by analysts at HSBC Holdings plc from a “buy” rating to a “hold” rating. They now have a $214.00 price target on the stock, up previously from $212.00. This represents a 7.3% downside from the current price of $230.76.
Sony Group (NYSE:SONY) was downgraded by analysts at Macquarie from an “outperform” rating to a “neutral” rating.The current price is $91.35.
SSR Mining (NASDAQ:SSRM) (TSE:SSO) was downgraded by analysts at Royal Bank of Canada from an “outperform” rating to a “sector perform” rating. They now have a $6.00 price target on the stock, down previously from $14.00. This represents a 25.0% upside from the current price of $4.80.
Twilio (NYSE:TWLO) was downgraded by analysts at Northland Securities from an “outperform” rating to a “market perform” rating. They now have a $66.00 price target on the stock. This represents a 7.1% upside from the current price of $61.62.
Westinghouse Air Brake Technologies (NYSE:WAB) was downgraded by analysts at Redburn Atlantic from a “buy” rating to a “neutral” rating. They now have a $135.00 price target on the stock. This represents a 1.2% upside from the current price of $133.35.
United States Steel (NYSE:X) was downgraded by analysts at Morgan Stanley from an “overweight” rating to an “equal weight” rating. They now have a $51.00 price target on the stock, up previously from $40.00. This represents a 11.6% upside from the current price of $45.68.
View today’s most recent analysts’ downgrades at MarketBeat.com

66,000% upside on tiny biotech? (ad)

The Wall Street Journal reports that this medical breakthrough is “Transforming Medicine.” One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today’s price.

Get all the details here >>>

Analysts’ New Coverage

Alnylam Pharmaceuticals (NASDAQ:ALNY) is now covered by analysts at Wolfe Research. They set a “peer perform” rating on the stock.The current price is $148.75.
Alpine Immune Sciences (NASDAQ:ALPN) is now covered by analysts at Wolfe Research. They set an “outperform” rating and a $44.00 price target on the stock. This represents a 48.0% upside from the current price of $29.73.
argenx (NASDAQ:ARGX) is now covered by analysts at Wolfe Research. They set a “peer perform” rating on the stock.The current price is $391.94.
Cullinan Oncology (NASDAQ:CGEM) is now covered by analysts at Wedbush. They set an “outperform” rating and a $30.00 price target on the stock. This represents a 65.1% upside from the current price of $18.17.
CRISPR Therapeutics (NASDAQ:CRSP) is now covered by analysts at Wolfe Research. They set a “peer perform” rating on the stock.The current price is $84.10.
CervoMed (NASDAQ:CRVO) is now covered by analysts at Canaccord Genuity Group Inc.. They set a “buy” rating and a $50.00 price target on the stock. This represents a 212.5% upside from the current price of $16.00.
CervoMed (NASDAQ:CRVO) is now covered by analysts at Canaccord Genuity Group Inc.. They set a “buy” rating and a $50.00 price target on the stock. This represents a 212.5% upside from the current price of $16.00.
Cisco Systems (NASDAQ:CSCO) is now covered by analysts at Wells Fargo & Company. They set an “equal weight” rating and a $52.00 price target on the stock. This represents a 6.0% upside from the current price of $49.04.
Deckers Outdoor (NYSE:DECK) is now covered by analysts at Evercore ISI. They set an “outperform” rating and a $960.00 price target on the stock. This represents a 11.6% upside from the current price of $860.42.
Dianthus Therapeutics (NASDAQ:DNTH) is now covered by analysts at Stifel Nicolaus. They set a “buy” rating and a $44.00 price target on the stock. This represents a 82.9% upside from the current price of $24.06.
Eastman Chemical (NYSE:EMN) is now covered by analysts at Redburn Atlantic. They set a “buy” rating and a $110.00 price target on the stock. This represents a 29.9% upside from the current price of $84.68.
Elastic (NYSE:ESTC) is now covered by analysts at Scotiabank. They set a “sector outperform” rating on the stock.The current price is $132.00.
GE HealthCare Technologies (NASDAQ:GEHC) is now covered by analysts at HSBC Holdings plc. They set a “buy” rating and a $100.00 price target on the stock. This represents a 18.2% upside from the current price of $84.61.
Monte Rosa Therapeutics (NASDAQ:GLUE) is now covered by analysts at Wedbush. They set an “outperform” rating and a $11.00 price target on the stock. This represents a 111.5% upside from the current price of $5.20.
Immunovant (NASDAQ:IMVT) is now covered by analysts at Wolfe Research. They set an “outperform” rating and a $55.00 price target on the stock. This represents a 45.3% upside from the current price of $37.85.
Insmed (NASDAQ:INSM) is now covered by analysts at Wolfe Research. They set an “outperform” rating and a $42.00 price target on the stock. This represents a 49.8% upside from the current price of $28.04.
JELD-WEN (NYSE:JELD) is now covered by analysts at Loop Capital. They set a “hold” rating and a $22.00 price target on the stock. This represents a 12.6% upside from the current price of $19.53.
Kymera Therapeutics (NASDAQ:KYMR) is now covered by analysts at Wolfe Research. They set a “peer perform” rating on the stock.The current price is $37.71.
MoonLake Immunotherapeutics (NASDAQ:MLTX) is now covered by analysts at Wolfe Research. They set an “outperform” rating and a $77.00 price target on the stock. This represents a 28.4% upside from the current price of $59.97.
Intellia Therapeutics (NASDAQ:NTLA) is now covered by analysts at Wolfe Research. They set a “peer perform” rating on the stock.The current price is $28.61.
RAPT Therapeutics (NASDAQ:RAPT) is now covered by analysts at Wolfe Research. They set an “outperform” rating and a $39.00 price target on the stock. This represents a 53.0% upside from the current price of $25.49.
Roivant Sciences (NASDAQ:ROIV) is now covered by analysts at Wolfe Research. They set an “outperform” rating and a $17.00 price target on the stock. This represents a 47.4% upside from the current price of $11.53.
Skechers U.S.A. (NYSE:SKX) is now covered by analysts at Evercore ISI. They set an “outperform” rating and a $73.00 price target on the stock. This represents a 21.2% upside from the current price of $60.22.
Super Micro Computer (NASDAQ:SMCI) is now covered by analysts at Bank of America Co.. They set a “buy” rating and a $1,040.00 price target on the stock. This represents a 7.8% upside from the current price of $964.74.
Savara (NASDAQ:SVRA) is now covered by analysts at JMP Securities. They set an “outperform” rating and a $8.00 price target on the stock. This represents a 60.3% upside from the current price of $4.99.
Vertex Pharmaceuticals (NASDAQ:VRTX) is now covered by analysts at Wolfe Research. They set an “outperform” rating and a $515.00 price target on the stock. This represents a 21.3% upside from the current price of $424.66.
View today’s most recent analysts’ new coverage at MarketBeat.com

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.

START YOUR 30-DAY FREE TRIAL

Calendars from MarketBeat

U.S. Analyst Ratings
Corporate Buybacks
Cryptocurrencies
Dividend Declarations
Earnings Announcements
Economic Reports
Gap Up/Down Stocks
Insider Trades
Initial Public Offerings (IPOs)
Most Active Stocks
Percentage Gainers/Decliners
Sector Performance
Short Interest
Unusual Options Volume
Unusual Trading Volume

Upgrade Your Subscription

Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET.

UPGRADE NOW

Manage Your Watchlist

View and add up to five holdings to your watchlist.

VIEW MY PORTFOLIO

Join Our Facebook Group

Join MarketBeat’s free stock discussion and trading idea group on Facebook.

JOIN NOW

Thank you for subscribing to MarketBeat!

We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that’s you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.

If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.

© 2006-2024 American Consumer News, LLC dba MarketBeat.
345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States.

Today’s Bonus Content: Elon Musk’s “Project Dojo” is a Game-Changer

Collagen Craze: 10 Compelling Reasons to Jump on the Peptide Bandwagon

thechefrecipe.com

RJ Hamster

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

🌎 Super Micro Computer Initiated, Ingredion Upgraded, Cleveland-Cliffs Downgraded and more…

🌎 Super Micro Computer Initiated, Ingredion Upgraded, Cleveland-Cliffs Downgraded…

Share this:

Like this:

Related articles